CN Patent

CN109789125B — 含有基于多粘菌素b/甲氧苄啶的治疗剂的药物组合物

Assigned to University of Rochester · Expires 2022-10-18 · 4y expired

What this patent protects

本发明的特征是一种抗菌组合物，其包含1)组合物A，所述组合物A包含多粘菌素B和甲氧苄啶；以及2)抗生素剂，所述抗生素剂选自由以下组成的组：利福平、利福布汀、利福喷汀、利福昔明、甲磺酸培氟沙星、司帕沙星、盐酸沙氟沙星、妥布霉素、洛美沙星、贝西沙星、甲磺酸达氟沙星、恩诺沙星、那氟沙星和克林沙星；其局部药物；以及使用1和2的混合物治疗细菌感染的方法。

USPTO Abstract

本发明的特征是一种抗菌组合物，其包含1)组合物A，所述组合物A包含多粘菌素B和甲氧苄啶；以及2)抗生素剂，所述抗生素剂选自由以下组成的组：利福平、利福布汀、利福喷汀、利福昔明、甲磺酸培氟沙星、司帕沙星、盐酸沙氟沙星、妥布霉素、洛美沙星、贝西沙星、甲磺酸达氟沙星、恩诺沙星、那氟沙星和克林沙星；其局部药物；以及使用1和2的混合物治疗细菌感染的方法。

Drugs covered by this patent

besifloxacin-hydrochloride (BESIFLOXACIN HYDROCHLORIDE)

Patent Metadata

Patent number: CN109789125B
Jurisdiction: CN
Classification: —
Expires: 2022-10-18
Drug substance claim: No
Drug product claim: No
Assignee: University of Rochester
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.